Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association between dietary patterns and body composition in normal-weight subjects with metabolic syndrome.
Rashidmayvan M, Sharifan P, Darroudi S, Saffar Soflaei S, Salaribaghoonabad R, Safari N, Yousefi M, Honari M, Ghazizadeh H, Ferns G, Esmaily H, Ghayour-Mobarhan M. Rashidmayvan M, et al. Among authors: honari m. J Diabetes Metab Disord. 2022 May 28;21(1):735-741. doi: 10.1007/s40200-022-01043-x. eCollection 2022 Jun. J Diabetes Metab Disord. 2022. PMID: 35673495 Free PMC article.
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18-55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial.
Ansarifar A, Farahani RH, Rahjerdi AK, Ahi M, Sheidaei A, Gohari K, Rahimi Z, Gholami F, Basiri P, Moradi M, Jahangiri A, Naderi K, Ghasemi S, Khatami P, Honari M, Khodaverdloo S, Shooshtari M, Azin HM, Moradi S, Shafaghi B, Allahyari H, Monazah A, Poor AK, Bakhshande H, Taghva Z, Nia MK, Dodaran MS, Foroughizadeh M. Ansarifar A, et al. Among authors: honari m. Vaccine X. 2023 Oct 27;15:100401. doi: 10.1016/j.jvacx.2023.100401. eCollection 2023 Dec. Vaccine X. 2023. PMID: 37941802 Free PMC article.
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial.
Solaymani-Dodaran M, Basiri P, Moradi M, Gohari K, Sheidaei A, Ahi M, Ghafoori Naeeni F, Ansarifar A, Rahimi Z, Gholami F, Karimi Rahjerdi A, Hamidi Farahani R, Naderi Saffar K, Ghasemi S, Shooshtari A, Honari M, Mozafari A, Khodaverdloo S, Forooghizadeh M. Solaymani-Dodaran M, et al. Among authors: honari m. Virol J. 2023 Jul 18;20(1):154. doi: 10.1186/s12985-023-02121-z. Virol J. 2023. PMID: 37464440 Free PMC article. Clinical Trial.
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18-70 years.
Gholami F, Hamidi Farahani R, Karimi Rahjerdi A, Ahi M, Sheidaei A, Gohari K, Rahimi Z, Ansarifar A, Basiri P, Moradi M, Jahangiri A, Naderi K, Ghasemi S, Khatami P, Honari M, Khodaverdloo S, Shooshtari M, Mehr Azin H, Moradi S, Shafaghi B, Allahyari H, Monazah A, Khodaei Poor A, Taghva Z, Bakhshande H, Karimi Nia M, Solaymani Dodaran M, Forooghizade M. Gholami F, et al. Among authors: honari m. BMC Infect Dis. 2023 Feb 24;23(1):118. doi: 10.1186/s12879-023-08079-1. BMC Infect Dis. 2023. PMID: 36829111 Free PMC article. Clinical Trial.
Skin cancers in Australia's Northern Territory 1981-85.
Saint-Yves IF, Honari M. Saint-Yves IF, et al. Among authors: honari m. J R Soc Health. 1988 Apr;108(2):69-74. doi: 10.1177/146642408810800214. J R Soc Health. 1988. PMID: 3131528 No abstract available.